According to a new report from Intel Market Research, the global single-use bioprocessing system for vaccine production market was valued at USD 1.1 billion in 2024 and is projected to reach USD 1.94 billion by 2032, growing at a robust CAGR of 8.6% during the forecast period (2025–2032). This growth is propelled by increasing global vaccine demand, technological advancements in...